中
About
Our Mission & Vision
Team
Leadership
Board of Directors
Scientific Advisory Board
Milestones
Pipeline
Ophthalmology
Neurology & Psychiatry
Partnership
Business Development
Our Partners
Newsroom
Press Releases
In The News
Media Room
Careers
Value & Behaviors
Benefits
Open Positions
Contact
About
Our Mission & Vision
Team
Milestones
Pipeline
Ophthalmology
Neurology & Psychiatry
Partnership
Business Development
Our Partners
Newsroom
Press Releases
In The News
Media Room
Careers
Value & Behaviors
Benefits
Open Positions
Contact
中
News
Press Releases
In The News
Media Room
Oct 29,2021
29
October 2021
AffaMed Therapeutics' Joint Venture Launched in Beijing to Advance Industry-Leading Solutions for Cataract Surgery in Greater China
Sep 17,2021
17
September 2021
AffaMed Therapeutics Announces Completion of First Patient Dosing of AM006 for Early Parkinson's Disease
Sep 06,2021
06
September 2021
AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases
Sep 03,2021
03
September 2021
AffaMed Therapeutics and Allgenesis Biotherapeutics Announce License Agreement for AG-73305 in Greater China Region
May 28,2021
28
May 2021
AffaMed Therapeutics Announces Approval for the Phase IIb Clinical Study of AM006 in China for the Treatment of Parkinson’s Disease
<<
<
1
2
3
4
5
>
>>
上一页
下一页
